CLINICAL PRACTICE GUIDELINES (FULL LIST)

DIABETIC KETOACIDOSIS (CPG)

Diabetic Ketoacidosis or DKA is a condition that occurs when there are critically low levels of insulin in the body. The body responds by burning fatty acids (ketogenesis) which produce acetone and betahydroxybutyric acid in very large amounts (acidosis) resulting in extreme dehydration, kidney failure, cardio-respiratory collapse, and death if not treated.

Diabetic Ketoacidosis team

Project Leader: Karishma Datye, MD, MSCI

Committee:

• Megan Malik, MD
• Jessica J. Anderson, PharmD, BCPPS
• Jennifer King, MD
• Austin Adair, MD
• Tammy Kodatt, RN BSN CCRN QIA
• Lesley Worsley-Hynd, MSN, RN, CCRN-K
• Yaa Kumah-Crystal, MD, MPH
• Jeffrey Birnbaum MD